A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Tekijät: Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JA, Cilia R, Ballanger B, Niethammer M, Stoessl JA
Kustantaja: WILEY
Julkaisuvuosi: 2017
Journal: Movement Disorders
Tietokannassa oleva lehden nimi: MOVEMENT DISORDERS
Lehden akronyymi: MOVEMENT DISORD
Vuosikerta: 32
Numero: 2
Aloitussivu: 181
Lopetussivu: 192
Sivujen määrä: 12
ISSN: 0885-3185
eISSN: 1531-8257
DOI: https://doi.org/10.1002/mds.26907
Tiivistelmä
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. (c) 2016 International Parkinson and Movement Disorder Society.
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. (c) 2016 International Parkinson and Movement Disorder Society.
Turun yliopiston Tutkimustietojärjestelmän portaali